Prevention of heart failure — is there a choice?

Authors:

Abstract
Effective treatment of arterial hypertension (AH) is important for preventing or delaying the development of chronic heart failure (CHF) and reducing associated hospitalizations and mortality. Despite the proven benefits of AH control, epidemiological data demonstrate that the effectiveness of antihypertensive therapy remains low at the population level. Combination therapy at the start of hypertension treatment is recommended for the majority of patients, and the combination of an angiotensin II receptor blocker and a diuretic is one of the most rational choices. This review systematizes studies on the use of azilsartan medoxomil with chlorthalidone in patients with CHF or at high risk of its development.

This publication has 38 references indexed in Scilit: